国药现代(600420.SH)：盐酸米那普仑获得化学原料药上市申请批准

智通财经02-24

智通财经APP讯，国药现代(600420.SH)发布公告，近日，公司全资孙公司江苏威奇达药业有限公司(以下简称国药江苏威奇达)收到国家药品监督管理局(以下简称国家药监局)核准签发的关于原料药盐酸米那普仑的《化学原料药上市申请批准通知书》。盐酸米那普仑是由法国皮尔法伯公司(PierreFabre)研发推广的一种口服选择性5-羟色胺和去甲肾上腺素再吸收抑制剂(SNRI)，用于治疗重度抑郁症。本次国药...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2613796206?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-02-24 17:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2613796206","market":"hk","top_or_hot":-1,"title":"国药现代(600420.SH)：盐酸米那普仑获得化学原料药上市申请批准","media":"智通财经","content":"<div>\n<p>智通财经APP讯，国药现代(600420.SH)发布公告，近日，公司全资孙公司江苏威奇达药业有限公司(以下简称国药江苏威奇达)收到国家药品监督管理局(以下简称国家药监局)核准签发的关于原料药盐酸米那普仑的《化学原料药上市申请批准通知书》。盐酸米那普仑是由法国皮尔法伯公司(PierreFabre)研发推广的一种口服选择性5-羟色胺和去甲肾上腺素再吸收抑制剂(SNRI)，用于治疗重度抑郁症。本次国药...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1406690.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>国药现代(600420.SH)：盐酸米那普仑获得化学原料药上市申请批准</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n国药现代(600420.SH)：盐酸米那普仑获得化学原料药上市申请批准\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-24 17:02 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1406690.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，国药现代(600420.SH)发布公告，近日，公司全资孙公司江苏威奇达药业有限公司(以下简称国药江苏威奇达)收到国家药品监督管理局(以下简称国家药监局)核准签发的关于原料药盐酸米那普仑的《化学原料药上市申请批准通知书》。盐酸米那普仑是由法国皮尔法伯公司(PierreFabre)研发推广的一种口服选择性5-羟色胺和去甲肾上腺素再吸收抑制剂(SNRI)，用于治疗重度抑郁症。本次国药...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1406690.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0132","symbol_name":"高送转概念","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1406690.html","article_id":"2613796206","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2613796206","pubTimestamp":1771923765,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，国药现代 发布公告，近日，公司全资孙公司江苏威奇达药业有限公司收到国家药品监督管理局核准签发的关于原料药盐酸米那普仑的《化学原料药上市申请批准通知书》。盐酸米那普仑是由法国皮尔法伯公司研发推广的一种口服选择性5-羟色胺和去甲肾上腺素再吸收抑制剂，用于治疗重度抑郁症。上述事项不会对公司当期经营业绩产生重大影响。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600420":"国药现代","BK0132":"高送转概念","BK0082":"国资改革","BK0010":"央企","BK0239":"医药制造","BK0020":"浦东新区"},"translate_title":"Sinopharm Modern (600420. SH): Milnacipran hydrochloride obtained approval for the marketing application of chemical raw materials","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600420":1.5},"content_text":"智通财经APP讯，国药现代(600420.SH)发布公告，近日，公司全资孙公司江苏威奇达药业有限公司(以下简称国药江苏威奇达)收到国家药品监督管理局(以下简称国家药监局)核准签发的关于原料药盐酸米那普仑的《化学原料药上市申请批准通知书》。盐酸米那普仑是由法国皮尔法伯公司(PierreFabre)研发推广的一种口服选择性5-羟色胺和去甲肾上腺素再吸收抑制剂(SNRI)，用于治疗重度抑郁症。本次国药江苏威奇达的盐酸米那普仑原料药获得上市申请批准，表明该原料药符合国家相关药品审批技术标准，可以在国内市场进行生产销售，有助于公司推进相关产品的产业链一体化，进一步优化公司资源配置和产业布局，提升公司产品的市场竞争力，为公司未来发展带来积极影响。上述事项不会对公司当期经营业绩产生重大影响。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2613796206","isCrawlerRequest":true}